Moolec Science SA Ordinary Shares (MLEC) - Total Assets
Based on the latest financial reports, Moolec Science SA Ordinary Shares (MLEC) holds total assets worth $31.38 Million USD as of March 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore cash flow to debt ratio of Moolec Science SA Ordinary Shares to assess how comfortably operating cash covers total debt obligations.
Moolec Science SA Ordinary Shares - Total Assets Trend (2021–2025)
This chart illustrates how Moolec Science SA Ordinary Shares's total assets have evolved over time, based on quarterly financial data. See MLEC net asset value for net asset value and shareholders' equity analysis.
Moolec Science SA Ordinary Shares - Asset Composition Analysis
Current Asset Composition (June 2025)
Moolec Science SA Ordinary Shares's total assets of $31.38 Million consist of 15.2% current assets and 84.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0.4% |
| Accounts Receivable | $19.92 Million | 9.7% |
| Inventory | $2.24 Million | 1.1% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $75.26 Million | 36.8% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2021–2025)
This chart illustrates how Moolec Science SA Ordinary Shares's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Moolec Science SA Ordinary Shares market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Moolec Science SA Ordinary Shares's current assets represent 15.2% of total assets in 2025, an increase from 0.4% in 2021.
- Cash Position: Cash and equivalents constituted 0.4% of total assets in 2025, up from 0.2% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 36.0% of total assets, an increase from 3.0% in 2021.
- Asset Diversification: The largest asset category is intangible assets at 36.8% of total assets.
Moolec Science SA Ordinary Shares Competitors by Total Assets
Key competitors of Moolec Science SA Ordinary Shares based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Ascendis Pharma AS
NASDAQ:ASND
|
USA | $2.01 Billion |
|
ALTEOGEN Inc
KQ:196170
|
Korea | ₩729.47 Billion |
|
Apogee Therapeutics, Inc. Common Stock
NASDAQ:APGE
|
USA | $1.29 Billion |
|
Definium Therapeutics, Inc.
NASDAQ:DFTX
|
USA | $440.10 Million |
|
Neuren Pharmaceuticals Ltd
AU:NEU
|
Australia | AU$331.25 Million |
|
Galapagos N.V.
AS:GLPG
|
Netherlands | €3.37 Billion |
|
Blue Jet Healthcare Limited
NSE:BLUEJET
|
India | Rs16.41 Billion |
|
Inventiva S.A
PA:IVA
|
France | €249.51 Million |
Moolec Science SA Ordinary Shares - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.48 | 0.85 | 0.02 |
| Quick Ratio | 0.73 | 0.80 | 0.02 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $3.09 Million | $-1.21 Million | $-293.86K |
Moolec Science SA Ordinary Shares - Advanced Valuation Insights
This section examines the relationship between Moolec Science SA Ordinary Shares's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.07 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | 488.5% |
| Total Assets | $204.71 Million |
| Market Capitalization | $4.89 Million USD |
Valuation Analysis
Below Book Valuation: The market values Moolec Science SA Ordinary Shares's assets below their book value (0.02x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Moolec Science SA Ordinary Shares's assets grew by 488.5% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Moolec Science SA Ordinary Shares (2021–2025)
The table below shows the annual total assets of Moolec Science SA Ordinary Shares from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | $204.71 Million | +488.47% |
| 2024-06-30 | $34.79 Million | +44.64% |
| 2023-06-30 | $24.05 Million | +322.57% |
| 2022-06-30 | $5.69 Million | -95.89% |
| 2021-06-30 | $138.59 Million | -- |
About Moolec Science SA Ordinary Shares
Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally. It develops nutritional supplements, food ingredients, meat replacements, and by-products using safflowers, chickpeas, fungi, soybeans… Read more